The treatment of asthma, hay fever or urticaria

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 3141

Patent

active

040298027

ABSTRACT:
There are described compounds of formula I, ##STR1## and pharmaceutically acceptable derivatives thereof, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are the same or are different and each is a hydrogen or halogen atom or an alkyl, hydroxy, alkoxy, or substituted alkyl or alkoxy group, (for example a hydroxy-alkoxy, alkoxyalkoxy or carboxyalkoxy group), and X is a saturated or unsaturated, substituted or unsubstituted, straight or branched hydrocarbon chain which may be interrupted by a carbocyclic or heterocyclic ring, or by one or more oxygen atoms or carbonyl groups. There are also described processes for making the compounds and pharmaceutical compositions, for the treatment of asthma, containing the compounds.

REFERENCES:
patent: 3671625 (1972-06-01), Altounyan
Juby et al. I, J. Med. Chem. vol. 12, pp. 396-401 (1969).
Juby et al. II, J. Med. Chem., vol. 11 pp. 111-117 (1968).
Buchananan et al., J. Med. Chem., vol. 12 pp. 1001-1006 (1969).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

The treatment of asthma, hay fever or urticaria does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The treatment of asthma, hay fever or urticaria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The treatment of asthma, hay fever or urticaria will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-10851

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.